Berberine potently inhibits protein tyrosine phosphatase 1B: Investigation by docking simulation and experimental validation

被引:35
作者
Bustanji, Yasser [1 ]
Taha, Mutasem O.
Yousef, Al-Motassem
Al-Bakri, Amal G.
机构
[1] Univ Jordan, Fac Pharm, Dept Biopharmaceut & Clin Pharm, Amman, Jordan
[2] Univ Jordan, Fac Pharm, Dept Pharmaceut Sci, Amman, Jordan
[3] Univ Jordan, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Amman, Jordan
关键词
berberine; tyrosine phosphatase; h-PTP; 1B; diabetes; docking simulations; inhibition;
D O I
10.1080/14756360500533026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Berberine was investigated as an inhibitor of human protein tyrosine phosphatase 1 B (h-PTP 1 B) in an attempt to explain its anti-hyperglycemic activitiy. The investigation included simulated docking experiments to fit berberine within the binding pocket of h-PTP 1B. Berberine was found to readily fit within the binding pocket of h-PTP 1B in a low energy orientation characterized with optimal electrostatic attractive interactions bridging the isoquinolinium positively charged nitrogen atom of berberine and the negatively charged acidic residue of ASP 48 of h-PTP I B. Experimentally, berberine was found to potently competitively inhibit recombinant h-PTP 1B in vitro (Ki value = 91.3 nM). Our findings strongly suggest that h-PTP 1B inhibition is at least one of the reasons for the reported anti-hyperglycemic activities of berberine.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 59 条
[1]   Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations [J].
Bissantz, C ;
Folkers, G ;
Rognan, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4759-4767
[2]   Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin actions [J].
Bleasdale, JE ;
Ogg, D ;
Palazuk, BJ ;
Jacob, CS ;
Swanson, ML ;
Wang, XY ;
Thompson, DP ;
Conradi, RA ;
Mathews, WR ;
Laborde, AL ;
Stuchly, CW ;
Heijbel, A ;
Bergdahl, K ;
Bannow, CA ;
Smith, CW ;
Svensson, C ;
Liljebris, C ;
Schostarez, HJ ;
May, PD ;
Stevens, FC ;
Larsen, SD .
BIOCHEMISTRY, 2001, 40 (19) :5642-5654
[3]   Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs [J].
Bohm, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1998, 12 (04) :309-323
[5]   Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells [J].
Boute, N ;
Boubekeur, S ;
Lacasa, D ;
Issad, T .
EMBO REPORTS, 2003, 4 (03) :313-319
[6]   Postprandial hyperglycemia and diabetes complications - Is it time to treat? [J].
Ceriello, A .
DIABETES, 2005, 54 (01) :1-7
[7]  
CHEN Q-M, 1987, Yaoxue Xuebao, V22, P161
[8]  
CHEN Q-M, 1986, Yaoxue Xuebao, V21, P401
[9]   Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent [J].
Cheon, HG ;
Kim, SM ;
Yang, SD ;
Du Ha, J ;
Choi, JK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 485 (1-3) :333-339
[10]   Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene [J].
Elchebly, M ;
Payette, P ;
Michaliszyn, E ;
Cromlish, W ;
Collins, S ;
Loy, AL ;
Normandin, D ;
Cheng, A ;
Himms-Hagen, J ;
Chan, CC ;
Ramachandran, C ;
Gresser, MJ ;
Tremblay, ML ;
Kennedy, BP .
SCIENCE, 1999, 283 (5407) :1544-1548